• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes.

作者信息

Raman Dayanidhi, Tiwari Amit K, Tiriveedhi Venkataswarup, Rhoades Sterling Julie A

机构信息

Department of Cancer Biology, University of Toledo Health Science Campus, Toledo, OH, United States.

Department of Pharmacology and Experimental Therapeutics, University of Toledo Health Science Campus, Toledo, OH, United States.

出版信息

Front Oncol. 2020 Mar 10;10:299. doi: 10.3389/fonc.2020.00299. eCollection 2020.

DOI:10.3389/fonc.2020.00299
PMID:32211328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7076080/
Abstract
摘要

相似文献

1
Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes.社论：乳腺癌干细胞在临床结局中的作用
Front Oncol. 2020 Mar 10;10:299. doi: 10.3389/fonc.2020.00299. eCollection 2020.
2
Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.三阴性乳腺癌中乳腺癌干细胞及肿瘤内干性异质性作为预后因素的评估
Int J Biol Sci. 2016 Dec 7;12(12):1568-1577. doi: 10.7150/ijbs.16874. eCollection 2016.
3
Heterogeneity and Plasticity of Breast Cancer Stem Cells.乳腺癌干细胞的异质性和可塑性。
Adv Exp Med Biol. 2019;1139:83-103. doi: 10.1007/978-3-030-14366-4_5.
4
Cytokines, breast cancer stem cells (BCSCs) and chemoresistance.细胞因子、乳腺癌干细胞（BCSCs）与化疗耐药性。
Clin Transl Med. 2018 Sep 3;7(1):27. doi: 10.1186/s40169-018-0205-6.
5
miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis.miR-200c/141 通过靶向 HIPK1/β-catenin 轴调控乳腺癌干细胞异质性。
Theranostics. 2018 Nov 10;8(21):5801-5813. doi: 10.7150/thno.29380. eCollection 2018.
6
Cancer stemness in bone marrow micrometastases of human breast cancer.人乳腺癌骨髓微转移中的肿瘤干细胞特性。
Surgery. 2018 Feb;163(2):330-335. doi: 10.1016/j.surg.2017.07.027. Epub 2017 Oct 5.
7
Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence.肿瘤微环境在癌症干细胞化疗耐药和复发中的作用。
Int J Biochem Cell Biol. 2018 Oct;103:115-124. doi: 10.1016/j.biocel.2018.08.011. Epub 2018 Aug 25.
8
Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.乳腺癌患者实体组织和液体组织中的癌症干细胞：特征与治疗前景
Curr Cancer Drug Targets. 2015;15(3):256-69. doi: 10.2174/1568009615666150211102503.
9
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.乳腺癌干细胞作为肿瘤化疗耐药、休眠和复发的驱动因素：新挑战与治疗机遇
Cancers (Basel). 2019 Oct 15;11(10):1569. doi: 10.3390/cancers11101569.
10
Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.纳米颗粒递送 miR-34a 通过直接靶向 C22ORF28 根除长期培养的乳腺癌干细胞。
Theranostics. 2017 Oct 17;7(19):4805-4824. doi: 10.7150/thno.20771. eCollection 2017.

引用本文的文献

1
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.三阴性乳腺癌中与化疗耐药相关的癌症干细胞存活途径的最新进展。
Future Oncol. 2025 Mar;21(6):715-735. doi: 10.1080/14796694.2025.2461443. Epub 2025 Feb 12.
2
Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment.乳腺癌中的缺氧诱导因子：在乳腺癌治疗中的作用和靶点。
Front Immunol. 2024 May 10;15:1370800. doi: 10.3389/fimmu.2024.1370800. eCollection 2024.
3
Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells.厚朴酚对转移性乳腺癌干细胞细胞周期抑制和免疫治疗靶点的综合计算分析
Evid Based Complement Alternat Med. 2022 Jul 8;2022:4172531. doi: 10.1155/2022/4172531. eCollection 2022.
4
Nanotechnological Approaches for the Treatment of Triple-Negative Breast Cancer: A Comprehensive Review.纳米技术在三阴性乳腺癌治疗中的应用：全面综述。
Curr Drug Metab. 2022;23(10):781-799. doi: 10.2174/1389200223666220608144551.
5
The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer.乳腺癌干细胞在三阴性乳腺癌化疗耐药和转移中的作用
Cancers (Basel). 2021 Dec 9;13(24):6209. doi: 10.3390/cancers13246209.
6
Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospects.橙皮苷及其苷元橙皮素在乳腺癌治疗中的应用：近期进展与未来展望综述
Saudi J Biol Sci. 2021 Dec;28(12):6730-6747. doi: 10.1016/j.sjbs.2021.07.046. Epub 2021 Jul 21.
7
Akt Isoforms: A Family Affair in Breast Cancer.Akt亚型：乳腺癌中的家族事务
Cancers (Basel). 2021 Jul 9;13(14):3445. doi: 10.3390/cancers13143445.
8
Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response.原发性乳腺癌干细胞的转录组谱可鉴定 ITGA7 作为化疗反应的预测标志物。
Br J Cancer. 2021 Sep;125(7):983-993. doi: 10.1038/s41416-021-01484-w. Epub 2021 Jul 12.
9
Targeting Histone Modifications in Bone and Lung Metastatic Cancers.靶向骨和肺转移癌中的组蛋白修饰。
Curr Osteoporos Rep. 2021 Jun;19(3):230-246. doi: 10.1007/s11914-021-00670-2. Epub 2021 Mar 15.
10
Hsa_circ_002178 Promotes the Growth and Migration of Breast Cancer Cells and Maintains Cancer Stem-like Cell Properties Through Regulating miR-1258/KDM7A Axis.Hsa_circ_002178 通过调控 miR-1258/KDM7A 轴促进乳腺癌细胞的生长和迁移并维持癌干细胞样细胞特性。
Cell Transplant. 2020 Jan-Dec;29:963689720960174. doi: 10.1177/0963689720960174.

本文引用的文献

1
The great escape: tumour cell plasticity in resistance to targeted therapy.肿瘤细胞的“大逃亡”：靶向治疗耐药中的可塑性。
Nat Rev Drug Discov. 2020 Jan;19(1):39-56. doi: 10.1038/s41573-019-0044-1. Epub 2019 Oct 10.
2
Targeting Cancer Stem Cells in Triple-Negative Breast Cancer.靶向三阴性乳腺癌中的癌症干细胞
Cancers (Basel). 2019 Jul 9;11(7):965. doi: 10.3390/cancers11070965.
3
"Energetic" Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy.“活跃型”癌症干细胞（e-CSCs）：一种由线粒体能量驱动的新型高代谢和增殖性肿瘤细胞表型
Front Oncol. 2019 Feb 5;8:677. doi: 10.3389/fonc.2018.00677. eCollection 2018.
4
Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs).起源癌细胞的特征：与“能量型”癌症干细胞（e-CSCs）的比较。
Aging (Albany NY). 2019 Feb 13;11(3):1065-1068. doi: 10.18632/aging.101822.
5
Stem Cells and Cellular Origins of Mammary Gland: Updates in Rationale, Controversies, and Cancer Relevance.干细胞与乳腺的细胞起源：理论依据、争议及与癌症的相关性的最新进展
Stem Cells Int. 2019 Jan 8;2019:4247168. doi: 10.1155/2019/4247168. eCollection 2019.
6
eIF4A inhibition: ready for primetime?真核起始因子4A抑制：准备好进入黄金时段了吗？
Oncotarget. 2018 Oct 30;9(85):35515-35516. doi: 10.18632/oncotarget.26268.
7
Breast cancer stem cells: Features, key drivers and treatment options.乳腺癌干细胞：特征、关键驱动因素和治疗选择。
Semin Cancer Biol. 2018 Dec;53:59-74. doi: 10.1016/j.semcancer.2018.07.007. Epub 2018 Jul 27.
8
Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling.靶向调控氧化还原信号平衡乳腺癌干细胞状态。
Cell Metab. 2018 Jul 3;28(1):69-86.e6. doi: 10.1016/j.cmet.2018.06.006.
9
eIF4A alleviates the translational repression mediated by classical secondary structures more than by G-quadruplexes.真核翻译起始因子 4A（eIF4A）缓解由经典二级结构介导的翻译抑制的能力强于由 G-四联体介导的能力。
Nucleic Acids Res. 2018 Apr 6;46(6):3075-3087. doi: 10.1093/nar/gky108.
10
Modeling of Interactions between Cancer Stem Cells and their Microenvironment: Predicting Clinical Response.癌症干细胞与其微环境之间相互作用的建模：预测临床反应。
Methods Mol Biol. 2018;1711:333-349. doi: 10.1007/978-1-4939-7493-1_16.